- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04495686
An Innovative Supportive Care Model for Dementia and Traumatic Brain Injury
There are an increasing number of people in the U.S. with Alzheimer's disease and other dementias. Traumatic brain injuries (TBIs) are also common among both civilians and military personnel, and TBIs increase a person's risk for dementia. Providing care for a person with dementia is stressful. Dementia caregivers can experience difficulties including stress, depression, and reduced quality of life. Coordinated dementia care is known to benefit people with dementia and their caregivers. However, many caregivers do not have access to these supportive programs.
Our project studies the benefits of telehealth as a new way for caregivers to receive coordinated dementia care services. We will offer 75 caregivers a 12-month caregiver support program delivered using telehealth (for example phones, tablets, computers). Caregivers of both Alzheimer's disease and TBI-related dementia will be included, and the program will be evaluated for effectiveness in both groups as well as in a control group. The information from our study will help improve quality of life for caregivers and individuals with dementia, including military members and Veterans. Our results will also help both civilian and military health professionals develop effective programs to support families living with dementia. Policy makers and organizational leaders can use the information to fund programs that best help families and communities facing dementia and TBI dementia.
Study Overview
Status
Intervention / Treatment
Detailed Description
More than 150,000 Virginians live with dementia. Most persons with dementia (PWD) are cared for by an unpaid family caregiver. These caregivers' provision of daily assistance to PWD is a critical part of the state's dementia care capabilities. Caregivers of PWD experience an array of negative biopsychosocial impacts related to their caregiving responsibilities that undermine their own well-being and their care capacity. They are often unprepared to manage the behavioral symptoms of dementia (BSD); unmanaged symptoms are associated with increased use of emergency care and institutional placement, which are burdensome outcomes for PWD, families, and public health systems.
An emergent body of research associates traumatic brain injury (TBI) with increased dementia risk. Veterans with a history of TBI are therefore at increased risk of developing dementia, putting their family members at risk for the established negative impacts of caregiving. Coordinated care programs have proven beneficial for both members of the dementia caregiving dyad, yet access barriers remain. Many caregivers have competing role responsibilities that conflict with consistent dementia care access, others are located in rural areas without access to specialized dementia care.
To surmount access barriers and countervail the negative impacts of caregiving, we propose an innovative, non-pharmacological intervention: a telehealth-delivered dementia care coordination program that provides family and caregiver support and will improve the quality of life (QoL) for both caregivers and PWD. A goal of our project is to fill an existing service gap by providing coordinated dementia care to an underserved population: caregivers of persons with TBI dementia.
Our study will test three primary hypotheses: 1) Caregivers of persons with dementia who participate in the telehealth care coordination program will experience greater improvements in study caregiver outcomes (depression, burden, reactions to BSD and QoL) than caregivers of PWD receiving best medical treatment (BMT); 2) Caregivers who participate in the program will experience greater satisfaction with care than caregivers in the BMT group; 3) The program will comparable benefits for caregivers of persons with Alzheimer's disease and related dementia (PWD-ADRD) and persons with TBI dementia (PWD-TBI).
In addition, our study includes three exploratory hypotheses: 1) Certain caregiver characteristics (external locus of control; lower self-efficacy, sense of hope, and self-perceived caregiver aptitude) will be negatively associated with improvements in caregiver study outcomes; 2) Caregivers in the intervention group will experience greater reductions in emergency/unnecessary health care utilization then caregivers in the BMT group; 3) The intervention will impart sustained caregiver benefits in primary study outcomes.
Project specific aims include: 1) Evaluate the benefits of a telehealth-delivered care coordination program intervention for caregivers of PWD relative to best medical treatment; 2) Evaluate the impact of the intervention on caregiver satisfaction; 3) Determine the comparative effectiveness of the care coordination program between caregivers of persons with ADRD those with TBI dementia; 4) Explore caregiver characteristics that influence intervention outcomes (burden, depression, QoL, responses to BSD); and 5) Investigate whether the intervention reduces emergency and unplanned health care utilization.
Our research strategy is a prospective, randomized, unblinded study investigating the benefits of a 12-month telehealth-delivered dementia care coordination intervention, with follow up assessments to examine the longevity of the intervention impacts. We will enroll 3 study groups: 50 caregivers of PWD-ADRD receiving the telehealth coordinated care intervention; 50 caregivers of PWD-ADRD receiving best medical treatment, and 25 caregivers of PWD-TBI receiving the intervention. We will collect baseline,12-, and 18-month data to examine intervention effectiveness on caregiver study outcomes and test the prolonged intervention effects.
Our study uses an innovative telehealth approach to provide care for families living with dementia. Family support has important implications at the individual, family, community, and national level. Strategies to reduce caregiver burden and improve QoL for civilian and military families can lead to greater satisfaction with care and prolong caregivers' capacity to keep their loved ones at home, reducing burdens on public payment systems, including the VA. Dissemination of study results will inform state and local policy and finance decisions that can help improve the lives of the growing population of persons with dementia or TBI dementia.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Virginia
-
Charlottesville, Virginia, United States, 22908
- University of Virginia
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Caregiver Inclusion Criteria:
- Must be at least 18 years of age
- Self-identified primary caregiver for a community-dwelling patient with dementia (PWD)
- Must be an unpaid caregiver
- Basic spoken and written English language skills
Caregiver Exclusion Criteria:
- Unwilling or unable to fulfill the requirements of the study
- Any condition which would make the caregiver, in the opinion of the investigator, unsuitable for the study
- No access to high-speed/broadband internet service capable of operating study teleconferencing software available
Patient with Dementia Inclusion Criteria:
- aged 55 years or older
- Diagnosis of mild cognitive impairment (MCI) or Alzheimer's disease and related dementias (ADRD)
- Mild to moderate dementia, including mixed dementia
- 0-1 appointments in the multi-disciplinary long-term University of Virginia (UVA) Memory Disorder follow-up clinic (MDC)
Patient with Dementia and TBI Inclusion Criteria:
- aged 21 years or older
- Diagnosis of major neurocognitive disorder (MND), mild neurocognitive disorder, or Alzheimer's disease and related dementias (ADRD)
- Diagnosis of mild to moderate dementia, including mixed dementia
- Diagnosed with mild complicated, moderate or sever traumatic brain injury (TBI)
- TBI event at or after the age of brain maturity, ≥25 years of age
No exclusion criteria for patients with dementia and/or traumatic brain injury.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Caregiver PWD-ADRD TCCI
Participants in the Caregiver PWD-ADRD telehealth care coordination intervention (TCCI) group will complete a 12-month telehealth-delivered care coordination program with an assigned dementia care coordinator.
|
Participants in the interventional arms of this program will be assigned a Dementia Care Manager (DCM) who will work with caregivers to develop goals and plans that are aimed at providing the best support possible, specific to your needs. These services include supportive counseling, education on dementia, information and referrals to community-based organizations, behavioral symptom management training and assistance with finding available community and government-sponsored programs. DCM's will meet with you at least once monthly and will be available if you need assistance between meetings. At the first meeting, your DCM will explain the questionnaires you will take and how to use the technology in the program. They will then provide a link, via email, where you will download the free teleconferencing software that will be used throughout the program. Questionnaires will then be sent via email invitations through a secure survey platform. |
No Intervention: Caregiver for PWD-ADRD (BMT)
Participants in the Caregiver PWD-ADRD best medical treatment (BMT) group will not receive care coordination.
|
|
Experimental: Caregiver for PWD-TBI TCCI
Participants in the Caregiver PWD-TBI telehealth care coordination intervention (TCCI) group will complete a 12-month telehealth-delivered care coordination program with an assigned dementia care coordinator.
|
Participants in the interventional arms of this program will be assigned a Dementia Care Manager (DCM) who will work with caregivers to develop goals and plans that are aimed at providing the best support possible, specific to your needs. These services include supportive counseling, education on dementia, information and referrals to community-based organizations, behavioral symptom management training and assistance with finding available community and government-sponsored programs. DCM's will meet with you at least once monthly and will be available if you need assistance between meetings. At the first meeting, your DCM will explain the questionnaires you will take and how to use the technology in the program. They will then provide a link, via email, where you will download the free teleconferencing software that will be used throughout the program. Questionnaires will then be sent via email invitations through a secure survey platform. |
No Intervention: Caregiver for PWD-TBI (BMT)
Participants in the Caregiver PWD-TBI best medical treatment (BMT) group will not receive care coordination.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Depression: Center for Epidemiologic Studies Depression Scale - Revised (CESD-R)
Time Frame: Change outcome measure at Baseline and 12 months and 18 months
|
The CESD-R assesses self-reported symptoms of depression.
The revised version was developed to reflect current understanding of psychiatric depressive symptoms.
The revised 20-item version is highly correlated with the original CESD, demonstrating test validity.
|
Change outcome measure at Baseline and 12 months and 18 months
|
Caregiver Burden: Zarit Burden Interview (ZBI)
Time Frame: Change outcome measure at Baseline and 12 months and 18 months
|
The ZBI is a 22-item caregiver self-report measure assessing degree of caregiver burden in caregivers of PWD.
The validated ZBI questions include measures of caregivers' health, finances, social supports, and psychological well-being.
|
Change outcome measure at Baseline and 12 months and 18 months
|
Caregiver Reactions to the Behavioral Symptoms of Dementia: Revised Memory and Behavior Problem Checklist (RMBPC)
Time Frame: Change outcome measure at Baseline and 12 months and 18 months
|
The RMBPC is a 24-item, caregiver-reported measure that assesses the frequency of problematic behaviors in patients with dementia and the severity of caregivers' reactions to these behaviors.
The reliability and validity of the RMBPC have been established.
|
Change outcome measure at Baseline and 12 months and 18 months
|
Quality of Life: WHO (Five) Well-Being Index (WHO-5)
Time Frame: Change outcome measure at Baseline and 12 months and 18 months
|
The WHO-5 contains five questions that measure well-being; scores range from 0-25, with higher scores representing higher QoL.
The WHO-5 is a validated tool that has been used successfully as an outcome measure in clinical trials across a wide range of study fields.
|
Change outcome measure at Baseline and 12 months and 18 months
|
Satisfaction with Care: Caregiver Satisfaction Survey (CSS)
Time Frame: Change outcome measure at 12 months and 18 months
|
The CSS is an investigator-developed survey that assesses satisfaction with care services.
|
Change outcome measure at 12 months and 18 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Healthcare Resource Utilization: Resource Utilization in Dementia, (RUD) questionnaire version 4.0.
Time Frame: Baseline, 12 months
|
The RUD v4.0 is a standardized, widely used instrument to collect resource use data in dementia.
Caregivers are asked to report resource utilization for both themselves and the person for whom they are caring.
|
Baseline, 12 months
|
Neuropsychiatric Symptoms and Caregiver Reactions: Neuropsychiatric Inventory Questionnaire (NPI-Q).
Time Frame: Baseline, 12 months
|
NPI is a validated instrument measuring 12 subdomains of psychopathology (e.g.
delusions, agitation/aggression, nighttime behavior) for persons with dementia as assessed by their caregivers.
Content and concurrent validity as well as inter-rater and test-retest reliability have been established.
|
Baseline, 12 months
|
Anxiety: Geriatric Anxiety Inventory (GAI).
Time Frame: Baseline, 12 months
|
The GAI comprises 20 items that measure self-reported symptoms of anxiety in older adults.
The GAI has established internal consistency, test-retest reliability, validity, and sensitivity.
|
Baseline, 12 months
|
Dementia Knowledge: Dementia Knowledge Assessment Tool Version 2 (DKAT2).
Time Frame: Baseline, 12 months
|
The DKAT2 assesses family caregivers' foundational-level knowledge of dementia and covers 2 domains: dementia and its progress, and dementia support and care.
The DKAT2's internal consistency, reliability, and content validity have been established.
|
Baseline, 12 months
|
Preparedness for Caregiving: Preparedness for Caregiving Scale (PCS).
Time Frame: Baseline, 12 months
|
The PCS is an 8-item self-report instrument that gauges how well caregivers believe they are prepared for multiple domains of caregiving, including providing physical care and emotional support, setting up home-based support services, and handing caregiver stress.
The scale's validity and reliability are established.
|
Baseline, 12 months
|
Self-Efficacy: General Self-Efficacy scale (GSE).
Time Frame: Baseline, 12 months
|
The GSE is a validated, reliable self-report measure of self-efficacy.
Scores on the 10-item scale range from 10-40, with higher scores indicating higher self-efficacy.
|
Baseline, 12 months
|
Optimism/Pessimism: Life-Orientation Test-Revised (LOT-R)
Time Frame: Baseline, 12 months
|
The LOT-R is a 10-item test that quantifies optimism.
The test has predictive and discriminate validity and can distinguish optimism from constructs such as depression, self-esteem, and self-mastery.
|
Baseline, 12 months
|
Basic Activities of Daily Living: Katz Index of Independence in Activities of Daily Living (Katz).
Time Frame: Baseline, 12 months
|
The KATZ is a validated measure of function used to objectively evaluate chronically ill and aging populations.
The measure ranks overall performances in six functions that indicate independence in 6 basic activities of daily living: bathing, dressing, toileting, transferring, feeding, and continence.
|
Baseline, 12 months
|
Instrumental Activities of Daily Living: Lawton Instrumental Activities of Daily Living Scale (Lawton).
Time Frame: Baseline, 12 months
|
The Lawton scale measures a person's level of independence in the completion of instrumental activities of daily living.
The validated scale detects functional decline across 8 domains: shopping, food preparation, taking medications, ability to handle finances or use a telephone, laundry, housekeeping, and transportation.
|
Baseline, 12 months
|
Quality of Life in PWD: Quality of Life in Alzheimer's Disease (QoL-AD).
Time Frame: Baseline, 12 months
|
The QoL-AD assesses quality of life reported by older adults with cognitive impairment and their caregivers.
The validated 10-minute test has good internal and test-retest reliability.
The 13 items were developed based on Lawton's scale for QoL domains and feedback from individuals with dementia and their caregivers.
|
Baseline, 12 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Carol Manning, Ph.D., University of Virginia Department of Neurology
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-HSR #15372
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- SAP
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alzheimer Disease
-
ProgenaBiomeRecruitingAlzheimer Disease | Alzheimer Disease, Early Onset | Alzheimer Disease, Late Onset | Alzheimer Disease 1 | Alzheimer Disease 2 | Alzheimer Disease 3 | Alzheimer Disease 4 | Alzheimer Disease 7 | Alzheimer Disease 17 | Alzheimer Disease 5 | Alzheimer Disease 6 | Alzheimer Disease 8 | Alzheimer Disease 10 | Alzheimer... and other conditionsUnited States
-
Cognito Therapeutics, Inc.RecruitingCognitive Impairment | Dementia | Alzheimer Disease | Mild Cognitive Impairment | Cognitive Decline | Alzheimer Disease, Early Onset | Alzheimer Disease, Late Onset | MCI | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Cognitive Impairment, Mild | Alzheimer Disease 1 | Dementia, Mild | Alzheimer... and other conditionsUnited States
-
AphiosNot yet recruitingDementia | Alzheimer Disease 1 | Alzheimer Disease 2 | Alzheimer Disease 3
-
Capital Medical UniversityPeking University First Hospital; The First Affiliated Hospital of Anhui Medical... and other collaboratorsRecruitingAlzheimer Disease | Familial Alzheimer Disease (FAD)China
-
University of PennsylvaniaNational Institute on Aging (NIA)CompletedDementia | Alzheimer Disease, At Risk | Alzheimer Disease, Protection AgainstUnited States
-
Kyoto UniversityOsaka University; Mie University; Tokushima University; Tokyo Metropolitan Geriatric... and other collaboratorsCompletedFamilial Alzheimer Disease (FAD) | PSEN1 MutationJapan
-
University of ArizonaNational Institute on Aging (NIA); University of Southern California; Syneos... and other collaboratorsRecruitingNeurodegenerative Diseases | Alzheimer Dementia | Late Onset Alzheimer DiseaseUnited States
-
National Taiwan Normal UniversityCompletedAlzheimer Disease 2 Due to Apoe4 IsoformTaiwan
-
Northwell HealthRecruitingAlzheimer Disease | Alzheimer Disease With Delusions | Alzheimer Disease With PsychosisUnited States
-
University of Kansas Medical CenterNational Institute on Aging (NIA)CompletedHealthy Aging | Alzheimer Disease 2 Due to Apoe4 IsoformUnited States
Clinical Trials on Telehealth-delivered Care Coordination Program
-
Weill Medical College of Cornell UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingMyocardial Infarction | Cardiovascular Diseases | Heart Failure | Stroke | Hypertension | Diabetes Mellitus | Atrial Fibrillation | Transient Ischemic Attack | Hyperlipidemias | Ischemic Heart DiseaseUnited States
-
Weill Medical College of Cornell UniversityBrown University; National Institute on Aging (NIA)Active, not recruiting
-
City University of New York, School of Public HealthNew York City Department of Health and Mental HygieneCompleted
-
National Taiwan University HospitalUnknownChronic Obstructive Pulmonary DiseaseTaiwan
-
Weill Medical College of Cornell UniversityMaimonides Medical Center; New York State Department of HealthCompletedHospital ReadmissionUnited States
-
Corporal Michael J. Crescenz VA Medical CenterCompleted
-
VA Office of Research and DevelopmentRecruitingDepression | Cardiovascular DiseasesUnited States
-
University of RochesterNot yet recruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Myelofibrosis | Myeloid Malignancy | Myelodysplastic/Myeloproliferative NeoplasmUnited States
-
NYU Langone HealthNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingPre DiabetesUnited States
-
University of California, San FranciscoNational Institute on Drug Abuse (NIDA); California HIV/AIDS Research ProgramCompletedMental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse) | Depression | HIV/AIDS | Substance UseUnited States